United States · FDA National Drug Code directory
HYALURONIDASE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 51662-1555_c3f1db01-58c0-2226-e053-2a95a90a8b33
- Product NDC
- 51662-1555
- Form
- INJECTION, SOLUTION
- Composition / generic term
- HYALURONIDASE
- Labeler
- HF Acquisition Co LLC, DBA HealthFirst
- Marketing category
- BLA
- Marketing start / end (source format)
- 20210604
- Source listing expiry
- 20261231
Source-listed ingredients
- HYALURONIDASE (HUMAN RECOMBINANT) — 150 [USP'U]/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL in 1 BOX (51662-1555-1) / 1 mL in 1 VIAL · 51662-1555-1
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →